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ABSTRACT 
Three substances are currently reported to possess cataract 
retardation properties: Scenecio Maritema, N-N dimethylglycine, 
and Conjunctivisan A. To test their potential in retarding 
cataract progression, Royal College of Surgeon (R.C.S.) rats 
were selected as the experimental model. This strain of rats 
develops posterior subcapsular cataracts secondarily to an in-
herited retinal degeneration. At birth, the rats were divided 
into four groups. The ten rats in each group received twice 
daily topical instillation of saline, Scenecio Maritema, N-N 
dimethylglycine, or Conjunctivisan A for eight weeks. Analysis 
of serial slit lamp evaluations showed a significant delay in 
cataract progression in the rats receiving any of the three 
agents compared to : the saline control. This suggests that there 
might be an alternative to surgery in cataract treatment. 
ii 
Cataract formation is one of the leading causes of 
blindness in the world today. 1 In the United States, aside from 
surgical removal of the lens, there is no medically accepted 
treatment for this condition. Recently, Naturopaths and other 
related health professionals have been using plant extracts in 
the form of topical drops to retard the formation of cataracts. 
Since a cataract can easily be detected early in its development, 
the topical applications of a substance capable of retarding cata-
ract development would provide an alternate method of treatment. 
However, these agents when applied topically have not been shown 
to significantly retard cataract formation in a carefully 
controlled study. 
There are three substances currently being used for cataract 
retardation: l) Scenecio Maritema, a plant extract; 2) N-N 
dimethylglycine (DMG) , the active agent in a group of substances 
called Pangamic Acid; and 3) Conjunctivisan A. 
Scenecio Maritema 
Succus Cineraria Maritema (SCM) or Scenecio Maritema are trade 
names for an herbal extract from the plant Cinereria Maritema. 
The sterilized juice of the plant is employed for the treatment of 
capsular and lenticular cataracts of the eye. Its use is recommended 
before resorting to an operation. 
Cinereria Maritema or Dusty Miller is a plant found most on 
the shores of the Mediterranean region. Cinereria means "ashy 
-1-
2 
grey", depicting its mixture of black and white coloring which 
contrasts against its yellow flowerheads. The juice from leaves 
are believed to contain a cataract retardant. When applied to the 
eye, it is thought to act as a lymphagogue, increasing circulation 
in the intraocular tissue and also stimulating collateral circu-
lation and normal metabolism. 
A pilot study has suggested retardation of cataract develop-
ment in Royal College of Surgeon (R.C.S.) rats treated with 
Scenecio Maritema as compared to placebo controls. 2 A recent 
pharmaceutical laboratory study was conducted investigating the 
use of SCM on the retardation of artificially induced cataracts 
in albino rats. Significant differences in light transmission 
values of the lenses between treated and non-treated animals were 
3 found. SCM has also been used in a study involving ophthal-
mologists instilling drops of SCM in human cataracts with favorable 
3 
results. 
N-N dimethylglycine 
N-N dimethylglycine (DMG) is a substance composed( of tertiary 
amino acids. This substance is referred to as being a non-fuel 
nutrient. In recent years, this composite has been referred to at 
times as Pangamic Acid or Vitamin B-15. This confusion has been 
settled by the extraction of only two common components--DMG and 
gluconic acid. There have been assertions that the component DMG 
has cataract retardation effects along with other medicinal cures. 
The apparent mechanism of DMG appears to be enhancement of 
oxygen utilization by tissues, complexing of free radicals, 4 
3 
detoxificationphenomenon of gluconic metabolism, and retardation 
of lactic acid build-up during physical and mental stress. 5 
Although this mechanism is not yet fully understood, it appears 
that these effects create a more efficient metabolic flow. 
Conjunctivisan ~ 
Conjunctivisan A (C-A) is the trade name for a pharmaceutical 
agent that is manufactured and utilized in Germany as an alternate 
treatment of cataracts. It is dispensed as a clear liquid in 
small disposable plastic vials. Topical administration into the 
conjunctival sac is intended for home usage two to three times 
daily, and the product cannot be filled without a prescription. 
The contents include: proteins, RNA, DNA, phospholipids, and poly-
saccharides; as well as, lens cell specific nucleic acids and amino 
acid precursors from the lens, vitreous body, retina, optic nerve, 
cornea, conjunctiva,and placenta. The macromolecular organic lysins 
are obtained from various eye tissues. Conjunctivisan A also 
includes Aesculin derivatives which are used as ultraviolet light 
filters, and it also contains Lantoside, a digitalis compound. 6 
In the utilization of Conjunctivisan A, anti-cataract therapy 
assumes that there are required amounts of necessary ingredients 
which are absent in the cataractous lens. By replenishing this 
deficient agent with an external vehicle such as Conjunctivisan A, 
the expected result would be a retardation in cataract formation. 
This requires that the topical drops be absorbed through the mucous 
membranes of the conjunctiva and transmitted to the lens. 
Conjunctivisan A has been described as an organotropism of 
cytoplasmic substances. 7 
4 
In 1979, Dr. J. Fuchs, a German ophthalmologist reported on 
his treatrrent in 192 cases of senile cataractous eyes with Con-
junctivisan A over a five year period. He concluded that 45% of 
the eyes treated demonstrated improved vision due to a decrease in 
lenticular opacification. Of the remaining patients, 36% showed 
no changes, and 19% followed the typical course of increased opaci-
fication and decreased vision. 8 
In order to determine the potential of the three agents to 
retard cataract progression, a suitable animal model was needed. 
R.C.S. rats which developed posterior subcapsular cataracts 
secondarily to an inherited retinal degeneration were used in 
this study because there has been extensive research on the 
. . 9 10 11 12 13 inherited retinal dystrophy 1n the stra1n of R.C.S. rats. ' ' ' ' 
The physical appearance is very similar to the tapetoretinal 
degeneration found in humans. 14 
In humans, the tapetoretinal degeneration in retinitis 
pigmentosa is characterized by rod outer segments not meeting 
with retinal pigment epithelium. This is due either to excessive 
phagocytosis of the outer segments or to incomplete development. 
In the R.C.S. rats, the rod outer segments are not phagocytized 
and they accumulate between the retinal receptor layer and the 
pigment epithelium of the retina. In both cases there is a gap 
between retinal receptors and pigment epithelium. This lack of 
development leads to the degeneration of the retina. 15 
5 
As a result of this retinal degeneration, a secondary 
posterior subcapsular cataract develops. The exact mechanism 
is yet unknown. The cataracts are grossly observable with a 
direct opthalmoscope as fine dust-like opacities approximately 
eight weeks after birth. The period of active cataractogensis 
occurs just prior to and during the active period of destruction 
9 10 
of the photoreceptors. ' 
According to an unpublished document on cataracts in R.C.S. 
rats, the major histological feature observed with the slit lamp 
is abnormal elongations of lens fibers toward the posterior pole. 16 
As the animal matures, normal tissue separates the initial dis-
oriented lens fibers from the lens capsule at the posterior pole. 16 
The influence of the retina on the differentiation of embryonic 
lens fibers is well documented. 17 The fully developed cataract 
can be observed approximate.ly twenty weeks after birth. 16 
Animals 
The animal subjects were forty outbred R.C.S. rats, which 
have been outbred and maintained over the past two years from 
a previous study involving the R.C.S. . 16 stra1n. The original 
6 
rats were obtained from Dr. Matthew LaVail and consisted of three 
brother-sister pairs. By crossbreeding the original R.C.S. rats 
with a Sprague-Dowley breed, a strain was developed that 
possessed a slower evo~ution of the retinal degeneration with less 
18 penetrance. This creates a much slower cataract progression than 
that observed in a purer R.C.S. breed when monitored by serial 
slit lamp evaluations. 
In an unpublished study by Dr. Steve Wells, 16 it was estimated 
that full cataract development occured after approximately five 
months of age without outbreeding. Due to the outbreeding of our 
R.C.S. breed, achievement of full cataract development took longer. 
This difference was not measured, since the achievement of a full-
blown cataract was not expected to occur during the eight week 
. 1 . d 16 exper1menta per1o . 
8 
The s-c group received an isotonic .9% NaCl saline solution pre-
pared daily from Baush and Lomb soflens tablets and distilled water. 
The other group of experimenters monitored cataract pro-
gression at weekly intervals during the same eight week period 
with the biomicroscope. Lens opacities were graded according to 
apparent size, location, and density. (See figure 1). Data 
was not computed or compared until the final. :data set had been 
collected at the end of the eighth week . 
The methods were consistent for all test groups wi·th the 
exception of C-A. The group. of ten rats was split into two 
groups of five. One group of the five rats received topical 
applications for a four week period which started at the beginning 
of the usual eight week experimental period. The second group 
of five rats received topical applications starting at the eighth 
week and continuing for four additional weeks. 
The randomization test for two independent samples was 
incorporated statistically to determine differences between the 
results in the rats each receiving the topical agent as compared 
to the rats receiving the saline. This was performed in order 
to isolate the different chemical agents and to see if there was 
a significant difference in the effect of each individual agent . 
A one tailed test was used to examine the research hypothesis 
that topical agents will retard cataract progression as 
compared to the saline control group. 
9 
Results 
Between the ages of four and seven weeks, posterior 
subcapsular cataracts were typically noted as the remnant 
hy aloid artery atrophied. There was no qualitative difference 
in cataract progression in animals of either sex or skin 
coloration . A d i fference in the rate of cataract progression 
was found between the s-c group for DMG and the other s-c groups. 
The rate of cataract progression in the DMG, S-C group was 
faster than those of the other two-SM, s-c, and C-A,S-C. The 
animals used in the D:MG group were obtained from an earlier 
generation of R.C.S. rats. Therefore, the rats in DMG and its 
S-C are a purer breed than the other rats used in the experiment. 
It has been mentioned earlier that as the strain is outbred, the 
period of time for cataract progression is extended. 18 
The cataract progression was noted to have been retarded in 
rats receiving DMG, SM, or C-A. The results are shown in Figures 
2a-2e. 
Statistical comparison showed that in the rats receiving 
DMG, SM, or C-A, cataract development was found to be significantly 
slower than in those rats receiving saline at all times. 
(Figure 2e). DMG showed a slightly larger amount of mean cataract 
retardation than did the other substances. SM showed just a 
little less mean cataract retardation effect than DMG (Figure 2a 
and 2b) . The two C-A groups did not show any significant mean 
retardation of cataract progression until the end of the fourth 
week of ·. use. 
10 
The results gathered show that the mean cataract develop-
ment in all the S-C animals followed a similar linear progression. 
The test animals receiving drops of the substances showed a 
similar mean retarding effect on cataract progression. Each 
substance delayed the development of the cataract to some degree. 
Discussion and Conclusions 
The physiolog·ical mechanism causing the development of 
secondary posterior subcapsular cataracts in R.C.S. rats may 
still be speculative, but the three topical agents employed 
11 
in this study have demonstrated perhaps an alteration in that 
mechanism . There appears to be differences in the mean 
results obtained on each of the substances u3ed. But in each 
case, the evidence of the results shows that cataract retardation 
has occurred to some degree (Figure 2a-2e) . 
When comparing the mean graphs on Figures 2a-2d, they all 
seem to be different; however, they take a similar time course and 
pattern. The molecular differences between the actual substances 
and their effect on cataract progression could possibly 
be the reason for varied results. One of these differences is 
the supposed mechanism . Both DMG and SCM are assumed to help 
facilitate normal metabolic flow, while C-A is assumed to re-
plenish lost nutrients. Although DMG and SCM are said to have 
the same mechanism, their origins differ. DMG is a non-fuel 
nutrient composed of tertiary amino acids. SCM is a plant extract. 
the other substance C-A is also d1fferent, being composed 
from an array of proteins and cytoplasmic substances found in 
the body . This difference may well explain the dissimilarities 
in the results between each substance. 
Another dissimilarity is noted when looking at Figure 2e . 
It is noted that the initial stage of cataractogenesis differs 
between test groups . The initial recorded stage of cataract 
12 
progression differs between DMG subjects and the other test 
groups probably because the DMG subjects were taken from an 
earlier generation, thus making it a purer R.C.S. breed. This 
would account for a more rapid cataract onset and development 
than those observed in following generations of R.C.s. 18 
The figures indicate that all three agents tested do retard 
cataract progression to some degree in this experimental model. 
However, because these animals also have retinal degeneration 
and no vision, the visual parameters associated with the retardation 
of cataract progression could not be assessed. Thus, this stujy 
suggests a potential for these agents to aid in the treatment of 
cataracts. The next step would have to be a follow-up clinical 
study which involves visual assessment in cataractous humans 
using these substances. If these substances truly retarded 
cataract formation sufficiently to provide useful vision, they 
would allow the cataract patient an alternative to surgery. 
13 
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STAGE ZERO: HYALOID REMNANTS 
Posterior Y-suture and hyaloid remnants 
only are observable shortly after birth when 
eyes open until the 4th week. 
STAGE ONE: INITIAL GRANULES 
A few minute granules bordering the Y-suture 
between the 4th and 5th week. 
STAGE TWO: DIFFUSE GRM~ULES 
Smaller and denser granules with early 
clouding of the posterior region at 5 
weeks of age. 
STAGE THREE: CIRCULAR 
Definite round-shaped border and increased 
clouding giving a translucent appearance 
at 6 and 7 weeks of age. 
STAGE FOUR: ANGULAR 
A more quadrilateral shape with denser and 
compacted form of translucency occuring 
at about 8 to 12 weeks of age. 
STAGE FIVE: FULL BLOWN 
Dense, white cataract (and opaque) develops 
in animals between 19 and 26 weeks of age. 
Figure 1. The cataract grading system used for assessing 
posterior subcapsular cataracts found in R.C . S . rats. 
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